Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive × Bevacizumab × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 49 Ovarian Neoplasms 29 Carcinoma, Hepatocellular 25 Neoplasms 16 Carcinoma, Non-Small-Cell Lung 16 Fallopian Tube Neoplasms 15 Colonic Neoplasms 10 Breast Neoplasms 9 Uterine Cervical Neoplasms 8 Liver Neoplasms 8 Rectal Neoplasms 7 Lung Neoplasms 7 Glioblastoma 7 Endometrial Neoplasms 7 Brain Neoplasms 7 Neoplasm Metastasis 6 Triple Negative Breast Neoplasms 5 Stomach Neoplasms 5 Recurrence 5 Carcinoma, Renal Cell 5 Carcinoma, Ovarian Epithelial 5 Small Cell Lung Carcinoma 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Colorectal Cancer Metastatic 4 Advanced Solid Tumors 4 Squamous Cell Carcinoma of Head and Neck 3 Medulloblastoma 3 Gastrointestinal Neoplasms 3 Digestive System Neoplasms 3 Carcinoma, Pancreatic Ductal 3

Interventions

Cyclophosphamide 3 fludarabine 2 Temozolomide 2 Eflornithine 2 ibrutinib 1 gallium Ga 68 dotatate 1 Standard of Care 1 Radiotherapy 1 Etoposide 1 Drug Therapy 1 CLR1404 1 Blood Specimen Collection 1 1-methyltryptophan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡